Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 13, 2025
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 16, 2025
Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial.
Journal: Nature communications
Published: December 06, 2024
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults.
Journal: Infectious diseases and therapy
Published: June 26, 2024
Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial.
Journal: The Lancet. Infectious diseases
Published: June 24, 2024
Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial.
Journal: Respiratory investigation
Published: March 06, 2024
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.
Journal: The Journal of infectious diseases
Published: February 07, 2024
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
Journal: The New England journal of medicine
Published: December 13, 2023
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults.
Journal: The Journal of infectious diseases
Published: October 05, 2023
Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
Journal: The Lancet. Infectious diseases
Published: March 08, 2018
Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.
Journal: PloS one
Published: September 14, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026